| Drug Type Interleukins | 
| Synonyms Recombinant Human Interleukin-2, Inleusin, 英路因 | 
| Target | 
| Action agonists | 
| Mechanism IL-2R agonists(Interleukin-2 receptor agonists) | 
| Therapeutic Areas | 
| Active Indication | 
| Inactive Indication- | 
| Originator Organization | 
| Active Organization | 
| Inactive Organization- | 
| License Organization- | 
| Drug Highest PhaseApproved | 
| First Approval Date China (01 Jan 1997),  | 
| Regulation- | 
| KEGG | Wiki | ATC | Drug Bank | 
|---|---|---|---|
| - | - | - | 
| Indication | Country/Location | Organization | Date | 
|---|---|---|---|
| Malignant Pleural Effusion | China  | 01 Jan 1997 | |
| Melanoma | China  | 01 Jan 1997 | |
| Pulmonary Tuberculosis | China  | 01 Jan 1997 | |
| Renal Cell Carcinoma | China  | 01 Jan 1997 | 






